Exercise Slows Epigenetic Aging in Breast Cancer Survivors After 12 Months
A randomized trial finds 12 months of exercise measurably slows biological aging clocks in breast cancer survivors and protects cognitive function.
Summary
Breast cancer treatment is known to accelerate biological aging, but a new study shows exercise can push back. Researchers enrolled 124 sedentary breast cancer survivors in a 12-month randomized trial, assigning them to either a remote exercise program or a health-and-wellness control. Using two DNA methylation-based clocks — GrimAge2 and DNAmFitAge — they found that the exercise group aged biologically more slowly than controls. Crucially, slower epigenetic aging tracked with better attention and self-reported cognitive function. Genome-wide analysis also turned up methylation changes in genes linked to BDNF signaling, a key pathway for brain health. The findings suggest that exercise doesn't just improve fitness — it may alter the molecular machinery of aging in cancer survivors, offering a lifestyle-based strategy to protect both healthspan and brain function after cancer treatment.
Detailed Summary
Cancer treatment is well recognized as a driver of accelerated biological aging, leaving breast cancer survivors at elevated risk of cognitive decline and premature age-related morbidity. Until now, it remained unclear whether lifestyle interventions could meaningfully reverse or slow these epigenetic trajectories.
This secondary analysis drew on data from a registered randomized controlled trial (NCT04049695) enrolling sedentary breast cancer survivors within five years of diagnosis. A subsample of 124 participants with complete epigenetic data was included. Participants were randomized to either a 12-month remotely delivered exercise program or a contact-matched health-and-wellness control condition. Whole blood samples were collected at baseline, six months, and twelve months, and epigenetic age was estimated using the Methylation Screening Array.
The exercise arm demonstrated significantly slower epigenetic aging relative to controls across both biological clocks tested: GrimAge2 (P = .02) and DNAmFitAge (P = .002). These clocks are among the strongest epigenetic predictors of morbidity and all-cause mortality, lending particular weight to the findings. Notably, changes in epigenetic aging correlated with cognitive outcomes — faster biological aging was associated with greater decline in attention and self-reported cognition, placing the epigenetic clock results in direct clinical context.
Genome-wide differential methylation analysis identified sites mapping to genes enriched in BDNF (brain-derived neurotrophic factor) signaling pathways, providing a plausible molecular mechanism by which exercise may sustain cognitive health. BDNF is a well-established mediator of neuroplasticity and is upregulated by aerobic exercise.
The implications extend beyond oncology. If a 12-month intervention can measurably slow two validated aging clocks, biological aging may be a broadly modifiable target. Caveats include the subsample size, an abstract-only basis for this summary, and the need to confirm findings in larger and more diverse cohorts.
Key Findings
- 12 months of exercise slowed epigenetic aging on both GrimAge2 and DNAmFitAge clocks versus controls.
- Faster epigenetic aging correlated with greater declines in attention and self-reported cognition.
- Genome-wide analysis linked exercise-related methylation changes to BDNF signaling pathways.
- The intervention was delivered remotely, suggesting scalability for cancer survivors outside clinical settings.
- Biological aging clocks appear to be modifiable targets for lifestyle intervention after breast cancer treatment.
Methodology
This is a secondary analysis of 124 participants from a randomized controlled trial (NCT04049695) comparing a 12-month remote exercise intervention to a contact-matched health-and-wellness control in sedentary breast cancer survivors. Epigenetic age was calculated from whole blood Methylation Screening Array data at baseline, six, and twelve months using GrimAge2 and DNAmFitAge clocks. Cognitive assessments were conducted at the same time points.
Study Limitations
This is a secondary analysis of a subset (n = 124) of a larger trial, limiting statistical power and generalizability. The summary is based on the abstract only, as the full text was not available, so methodological details such as exercise type, intensity, and adherence rates could not be fully assessed. Replication in larger, more diverse populations and longer follow-up periods are needed to confirm durability of epigenetic effects.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: